are compound glp 1 going away Is Semaglutide Away? Understanding the Future of This Weight Loss Option – PlexusDx GLP-1 online advertising overstates benefits

In a 2021 clinical trial published in The New England Journal of Medicine, patients taking Semaglutide lost an average of 14.9% of their body weight over 68 weeks

Researchers should conduct all work in compliance with applicable institutional review board (IRB) protocols, local regulations, and ethical guidelines

Nausea-induced decreased oral intake further reduces hydration and electrolyte balance

To view or add a comment, sign in What happens when a clinical trial needs to shift midstream

In those same high-adoption areas, FSR wallet share rose from 7.68% to 9.05%, suggesting GLP-1 users are trading convenience dining for more experiential occasions. The 35-54 cohort is the key commercial segment here: unlike older users who are broadly cutting back, this group is eating out more (38% report increased frequency), spending more per occasion, and trading up in quality